CIMZIA® (certolizumab pegol) is Now the First and Only U.S. FDA-Approved Treatment for Non-Radiogra - PharmiWeb.com

CIMZIA® (certolizumab pegol) is Now the First and Only U.S. FDA-Approved Treatment for Non-Radiogra  PharmiWeb.com

BRUSSELS, March 28, 2019 /PRNewswire/ -- UCB, a global biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) ...



Comments

Post a Comment

Popular posts from this blog